business

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio - PR Newswire

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") and Chimerix (Nasdaq: CMRX) ("Chimerix"), today announced the companies have...

Source:PRNewswire
Published:
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio - PR Newswire
-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors- -Transaction to add near-term commercial opportunity to Jazz's pipeline-  -Transaction repr… [+17513 chars]

Related News